Andromeda Capital’s Intuitive Surgical ISRG Stock Holding History

Andromeda Capital’s Portfolio ISRG Stock Details ISRG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-9,540	Closed	-$407K	–	123
2013 Q4	$407K	Buy	+9,540	New	+$401K	0.06%	84

Other funds holding ISRG

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Andromeda Capital's ISRG Position: Q1 2014 in Review

Andromeda Capital sold out of Intuitive Surgical (ISRG) in Q1 2014, closing a stake of 9,540 shares — an estimated $407K sold.

Andromeda Capital first reported a position in ISRG in Q4 2013 and held it in 1 quarter. The position peaked at $407K in Q4 2013. 481 funds tracked by Wall St. Rank hold ISRG as of Q1 2014.

Andromeda Capital reported no remaining Intuitive Surgical position as of Q1 2014 after selling out during the quarter.
Andromeda Capital sold 9,540 Intuitive Surgical shares in Q1 2014, an estimated $407K.
Andromeda Capital first reported a position in Intuitive Surgical in Q4 2013 and held it in 1 quarter.
Andromeda Capital's Intuitive Surgical position peaked at $407K in Q4 2013.
481 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2014.

Based on Andromeda Capital's 13F filing for Q1 2014, filed 15 May 2014.